Notice2023-25327

Agency Information Collection Activities; Proposed eCollection eComments Requested; Regulated Transactions in Tableting/Encapsulating Machines

Primary source

Metadata and text below are from the Federal Register, a public-domain U.S. government work. Always verify the official published version before relying on it for any legal matter.

Published
November 16, 2023

Issuing agencies

Justice Department

Abstract

The Drug Enforcement Administration (DEA), Department of Justice (DOJ), will be submitting the following information collection request to the Office of Management and Budget (OMB) for review and approval in accordance with the Paperwork Reduction Act of 1995. This proposed information collection was previously published in the Federal Register on September 11, 2023, allowing for a 60-day comment period.

Full Text

<html>
<head>
<title>Federal Register, Volume 88 Issue 220 (Thursday, November 16, 2023)</title>
</head>
<body><pre>
[Federal Register Volume 88, Number 220 (Thursday, November 16, 2023)]
[Notices]
[Page 78792]
From the Federal Register Online via the Government Publishing Office [<a href="http://www.gpo.gov">www.gpo.gov</a>]
[FR Doc No: 2023-25327]


-----------------------------------------------------------------------

DEPARTMENT OF JUSTICE

[OMB Number 1117-0024]


Agency Information Collection Activities; Proposed eCollection 
eComments Requested; Regulated Transactions in Tableting/Encapsulating 
Machines

AGENCY: Drug Enforcement Administration, Department of Justice.

ACTION: 30-Day notice.

-----------------------------------------------------------------------

SUMMARY: The Drug Enforcement Administration (DEA), Department of 
Justice (DOJ), will be submitting the following information collection 
request to the Office of Management and Budget (OMB) for review and 
approval in accordance with the Paperwork Reduction Act of 1995. This 
proposed information collection was previously published in the Federal 
Register on September 11, 2023, allowing for a 60-day comment period.

DATES: Comments are encouraged and will be accepted for 30 days until 
December 18, 2023.

FOR FURTHER INFORMATION CONTACT: If you have comments especially on the 
estimated public burden or associated response time, suggestions, or 
need a copy of the proposed information collection instrument with 
instructions or additional information, please contact Scott A. Brinks, 
Regulatory Drafting and Policy Support Section, Drug Enforcement 
Administration; Mailing Address: 8701 Morrissette Drive, Springfield, 
Virginia 22152; Telephone: (571) 362-3261, email: 
<a href="/cdn-cgi/l/email-protection#3546565a41411b541b57475c5b5e46755150541b525a43"><span class="__cf_email__" data-cfemail="2053434f54540e410e4252494e4b53604445410e474f56">[email&#160;protected]</span></a>.

SUPPLEMENTARY INFORMATION:  Written comments and suggestions from the 
public and affected agencies concerning the proposed collection of 
information are encouraged. Your comments should address one or more of 
the following four points:

--Evaluate whether the proposed collection of information is necessary 
for the proper performance of the functions of the agency, including 
whether the information will have practical utility;
--Evaluate the accuracy of the agency's estimate of the burden of the 
proposed collection of information, including the validity of the 
methodology and assumptions used;
--Enhance the quality, utility, and clarity of the information to be 
collected; and/or
--Minimize the burden of the collection of information on those who are 
to respond, including through the use of appropriate automated, 
electronic, mechanical, or other technological collection techniques or 
other forms of information technology, e.g., permitting electronic 
submission of responses.

    Written comments and recommendations for this information 
collection should be submitted within 30 days of the publication of 
this notice on the following website <a href="http://www.reginfo.gov/public/do/PRAMain">www.reginfo.gov/public/do/PRAMain</a>. 
Find this particular information collection by selecting ``Currently 
under 30-day Review--Open for Public Comments'' or by using the search 
function and entering either the title of the information collection or 
the OMB Control Number 1117-0024. This information collection request 
may be viewed at <a href="http://www.reginfo.gov">www.reginfo.gov</a>. Follow the instructions to view 
Department of Justice, information collections currently under review 
by OMB.
    DOJ seeks PRA authorization for this information collection for 
three (3) years. OMB authorization for an ICR cannot be for more than 
three (3) years without renewal. The DOJ notes that information 
collection requirements submitted to the OMB for existing ICRs receive 
a month-to-month extension while they undergo review.

Overview of This Information Collection

    1. Type of Information Collection: Revision of a currently approved 
collection.
    2. Title of the Form/Collection: Regulated Transactions in 
Tableting/Encapsulating Machines.
    3. Agency form number, if any, and the applicable component of the 
Department of Justice sponsoring the collection: DEA Form 452. The 
applicable component within the Department of Justice is the Drug 
Enforcement Administration, Diversion Control Division.
    4. Affected public who will be asked or required to respond, as 
well as a brief abstract: Affected public (Primary): Business or other 
for-profit. Affected public (Other): Not-for-profit institutions; 
Federal, State, local, and tribal governments.
    Abstract: Each regulated person is required to report any unusual 
or excessive loss or disappearance of a listed chemical, and any 
regulated transaction in a tableting or encapsulating machine, to 
include any domestic regulated transaction in a tableting or 
encapsulating machine and any import or export of a tableting or 
encapsulating machine. 21 U.S.C. 830 (b)(1)(A), (C) and (D); 21 CFR 
1310.05(a)(1), (3)-(4); 21 CFR 1310.05(c). Regulated persons include 
manufacturers, distributors, importers, and exporters of listed 
chemicals, tableting machines, or encapsulating machines, or persons 
who serve as brokers or traders for international transactions 
involving a listed chemical, tableting machine, or encapsulating 
machine. 21 CFR 1300.02(b). This report will be submitted 
electronically. DEA will be modifying this collection (1117-0024) and 
collection 1117-0001 by removing Form 107 from this collection and 
adding it to 1117-0001 because DEA Form 107 is more aligned with DEA 
Form 106 (which is approved under 1117-0001).
    5. Obligation to Respond: Mandatory per 21 CFR 1310.
    6. Total Estimated Number of Respondents: 274.
    7. Estimated Time per Respondent: 33 minutes.
    8. Frequency: 92.
    9. Total Estimated Annual Time Burden: 8,367 hours.
    10. Total Estimated Annual Other Costs Burden: $0.
    If additional information is required, contact: Darwin Arceo, 
Department Clearance Officer, Policy and Planning Staff, Justice 
Management Division, United States Department of Justice, Two 
Constitution Square, 145 N Street NE, 4W-218 Washington, DC 20530.

    Dated: November 8, 2023.
Darwin Arceo,
Department Clearance Officer for PRA, U.S. Department of Justice.
[FR Doc. 2023-25327 Filed 11-15-23; 8:45 am]
BILLING CODE 4410-09-P


</pre><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script></body>
</html>
Indexed from Federal Register on November 16, 2023.

This is legal information, not legal advice. Laws vary by jurisdiction and change frequently. Always verify current law with official sources and consult a licensed attorney in your jurisdiction for advice on your specific situation.